MYRO THERAPEUTICS

Our mission is to develop first-in-class and best-in-class small molecule drugs for neuroimmune, demyelinating, neurodegenerative, and neuropsychiatric disorders... We are excited to welcome Nathan Parker to the Neuropharmacology unit at Myro. He joins us from Rockefeller University, and will be a great addition to the team!

Also known as: Myro, Myro Therapeutics, Inc.

Primary location: Watertown United States